Dyne Therapeutics, Inc.
DYNNasdaqCIK 1818794HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2920:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001818794-26-000009 |
| 2026-07-2920:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-323940 |
| 2026-07-2920:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-323639 |
| 2026-07-2221:19 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-312571 |
| 2026-07-2011:35 ET | 8-K | 8.01 Other events | 0001193125-26-308343 |
| 2026-06-2220:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001818794-26-000005 |
| 2026-06-1711:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001818794-26-000003 |
| 2026-06-0820:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-261696 |
| 2026-06-0311:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-254597 |
| 2026-05-1111:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-215720 |
| 2026-05-1111:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-215702 |
| 2026-04-2320:05 ET | DEF 14A | Proxy statementPeriod 2026-04-22 | 0001193125-26-173655 |
| 2026-03-0212:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-084207 |
| 2026-03-0212:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-084178 |
| 2026-01-1212:35 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009782 |
| 2025-12-2312:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-329511 |
| 2025-12-1021:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314249 |
| 2025-12-0821:07 ET | 8-K | 2.03 New direct financial obligation | 0001193125-25-311221 |
| 2025-12-0811:36 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310516 |
| 2025-11-0521:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266979 |
| 2025-11-0521:05 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266882 |
| 2025-10-0220:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-228317 |
| 2025-08-0411:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-101620 |
| 2025-07-2820:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-099184 |
| 2025-07-2820:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-099161 |
| 2025-07-0120:40 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-154057 |
| 2025-06-3020:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-152652 |
| 2025-06-1711:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-141739 |
| 2025-06-0520:09 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-082317 |
| 2025-05-0811:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066396 |
| 2025-05-0811:25 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066386 |
| 2025-04-1511:34 ET | DEF 14A | Proxy statementPeriod 2025-05-30 | 0000950170-25-053950 |
| 2025-03-2020:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-058979 |
| 2025-02-2712:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028369 |
| 2025-02-2712:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028356 |
| 2025-01-1011:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-004057 |
| 2024-11-1214:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-255269 |
| 2024-11-1212:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-124583 |
| 2024-11-1212:25 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-124572 |
| 2024-09-0311:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-211534 |
| 2024-08-1221:15 ET | 8-K | 2.02 Results of operations | 0000950170-24-095537 |
| 2024-08-1221:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095527 |
| 2024-05-2421:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-064700 |
| 2024-05-2211:59 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-144470 |
| 2024-05-2011:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-142232 |
| 2024-05-0220:15 ET | 8-K | 2.02 Results of operations | 0000950170-24-052142 |
| 2024-05-0220:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052066 |
| 2024-04-0520:15 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0000950170-24-042276 |
| 2024-03-2511:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-075932 |
| 2024-03-0512:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-025408 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.